End-Stage Liver Disease

End-stage liver disease (ESLD) occurs when the liver is severely damaged due to a variety of causes, including chronic alcohol abuse, hepatitis B and C, non-alcoholic fatty liver disease (NAFLD) and metabolic disorders. In ESLD, the liver can no longer perform its normal functions, including the production of essential proteins, bile, and other substances necessary for proper digestion and metabolism. This can lead to serious complications, including jaundice, ascites (fluid buildup in the abdomen), hepatic encephalopathy (confusion due to liver dysfunction), and bleeding from varices (enlarged veins in the esophagus). ESLD is a progressive disease that can be managed, but not cured. Treatment focuses on managing symptoms and preventing complications. Medications may be prescribed to reduce the risk of infection, reduce bleeding from varices, and manage ascites. Dietary modifications may be necessary to reduce symptoms and limit the risk of complications. Regular monitoring and medical follow-up are also important to ensure that medications are working properly and to monitor liver function. In some cases, liver transplantation may be the only option for individuals with ESLD. Transplantation is a major surgery that carries risks, but for some individuals it may be the only way to treat their ESLD. Due to the risks associated with liver transplantation, it is typically reserved for individuals with the most severe cases of ESLD who are not responding to other treatments. No matter the stage of ESLD, it is important to seek medical attention early to ensure that the condition is monitored and managed appropriately. With proper medical management and lifestyle modifications, individuals with ESLD can often achieve better outcomes and improved quality of life.